Abstract
Analysis of the crystal structure of human class II (HLA-DR1) molecules suggests that the αβ heterodimer may be further ordered as a dimer of heterodimers (superdimer), leading to the hypothesis that T cell receptor dimerisation is a mechanism for initiating signaling events preceding T cell activation. The interface between pairs of molecules is stabilised by both salt bridges, polar and hydrophobic interactions. The residues that form the superdimer interface occur in three areas distinct from the antigen-binding groove. They can be defined as follows: region 1, β-β contacts in the helix of the β1 domain; region 2, α-α contacts near the α1/α2 domain junction and region 3; α-β contacts in the α2/β2 domains adjacent to the plasma membrane. To determine whether salt bridges and polar interactions formed within these regions are involved in the immune function of the murine MHC class II molecule, I-Ab, appropriate residues in both the α and β chain were identified and mutated to uncharged alanine. Cell lines transfected with different combinations of mutated α and β chains were generated and tested for MHC class II expression, peptide binding capabilities, and ability to present antigenic peptide to an OVA-specific T cell hybridoma. With the exception of two residues in region 2, the substitutions tested did not modulate MHC class II expression, or peptide binding function. When tested for ability to present peptide to an antigen-specific T cell hybridoma, with the exception of mutations in region 2, the substitutions did not appear to abrogate the ability of I-Ab to stimulate the T cells. These results suggest that mutation of residues in region 2 of the putative superdimer interface have a gross effect on the ability of I-Ab to be expressed on the cell surface. However, abrogation of salt bridges in region 1 and 3 do not influence I-Ab cell surface expression, peptide binding or ability to stimulate antigen-specific T cells.
Similar content being viewed by others
References
Watts C: Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15: 821–850, 1997
Robinson JH, Delvig, AA: Diversity in MHC class II antigen presentation. Immunology 105: 252–262, 2002
Roche PA, Marks MS, Cresswell P: Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354: 392–394, 1991
Pieters J, Bakke O, Dobberstein B: The MHC class II-associated invariant chain contains two endocytic targetting signals within in its cytoplasmic tail. J Cell Sci 106: 831–842, 1993
Odorizzi CG, Trowbridge IS, Xue L, Hopkins CR, Davis CD, Collawn JF: Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to the endocytoplasmic processing compartment. J Cell Biol 126: 317–330, 1994
Amigorena S, Drake JR, Webster P, Mellman I: Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369: 113–120, 1994
Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I: Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 181: 1729–1741, 1995
Denzin LK, Cresswell P: HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82: 155–165, 1995
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 509–512, 1987
Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33–39, 1993
Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC: Structure of the complex between human T cell receptor, viral peptide and HLA-A2. Nature 384: 134–141, 1996
Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA: An alpha-beta T cell receptor structure at 2.5 angstrom and its orientation in the TCR-MHC complex. Science 274: 209–219, 1996
Reinherz EL, Tan K, Tang L, Kern P, Liu JH, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, Joachimiak A, Chang HS, Wagner G, Wang JH: The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286: 1913–1921, 1999
Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHCprotein HLA-DR1complexed withan influenza virus peptide. Nature 368: 215–221, 1994
Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi Y, Stauffacher C, Strominger JL, Wiley DC: Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368: 711–718, 1994
Kim J, Urban RG, Strominger JL, Wiley DC: Toxic shock syndrome toxin-1 complexed with class II histocompatibility molecule HLA-DR1. Science 266: 1870, 1994
Brown JH, Jardetzky TS, Stern LJ, Gorga JC, Strominger JL, Wiley DC: Human class II molecule HLA-DR1: X-ray structure determined from three crystal forms. Acta Cryst D51: 946–961, 1995
Fremont DH, Hendrickson WA, Marrack P, Kappler J: Structures of an MHC class II molecule with covalently bound single peptides. Science 272: 1001–1004, 1996
Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden BC, Ysern X, Kim JK, Shao X, Ward ES, Mariuzza RA: Crystal structure of the Vα domain of a T cell antigen receptor. Science 270: 1821–1824, 1995
Schafer PH, Pierce SK: Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1: 699–707, 1994
Roucard C, Garban F, Mooney NA, Charron DJ, Ericson ML: Conformation of human leukocyte antigen class II molecules: Evidence for superdimers and empty molecules on human antigen presenting cells. J Biol Chem 271: 13993–14000, 1996
Hitzel C, Gruneberg U, van Ham M, Trowsdale J, Koch N: Sodium dodecyl sulphate-resistant HLA-DR “superdimer” bands are in some cases class II heterodimers bound to antibody. J Immunol 162: 4671–4676, 1999
Cherry RJ, Wilson KM, Triantafilou K, O’Toole P, Morrison IEG, Smith PR, Fernandez N: Detection of dimers of dimers of human leukocyte antigen (HLA)-DR on the surface of living cells by single-particle fluorescence imaging. J Cell Biol 140: 71–79, 1998
Reich Z, Boniface JJ, Lyons DS, Borochov N, Wachtel EJ, Davis MM: Ligand-specific oligomerisation of T cell receptor molecules. Nature 387: 617–620, 1997
Lake RL, Robinson BWS, Hayball JD: MHC multimerisation, antigen expression and the induction of APC amnesia in the developing immune response. Immunol Cell Biol 77: 99–104, 1999
Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JR: Effects of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J Immunol 147: 1292–1298, 1991
Hewitt CR, Lamb JR, Hayball J, Hill M, Owen MJ, O’Hehir RE: Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med 175: 1493–1499, 1992
Mizushima S, Nagata S: pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18: 5322, 1990
Hayball JD, Jones CM, Lamb JR, Lake RA: A T cell clone with three potential TCR alpha chain rearragements expresses only one receptor combinantion at the cell surface. Mol Immunol 33: 1177–1181, 1996
Morgenstern JP, Land H: A series of mammalian expression vectors and characterisation of their expression of reporter gene in stably and transiently transfected cells. Nucleic Acids Res 18: 1068, 1990
Janeway CA, Conrad PJ, Lerner EA, Babich J, Wettstein P, Murphy DB: Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: Possible role of T cell bound Ia antigenis as targets of immunoregulatory T cells. J Immunol 132: 662–667, 1984
Bhattacharya A, Dorf ME, Springer TA: A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: Evidence for I region gene duplication. J Immunol 127: 2488–2495, 1981
Eastman S, Deftos M, DeRoos PC, Hsu DH, Teyton L, Braunstein NS, Hackett CJ, Rudensky A: A study of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody. Eur J Immunol 26: 385–393, 1996
Kristensen NM, Hoyne G, Hayball JD, Hetzel C, Bourne T, Lamb JR: Induction of T cell responses to the invariant chain derived CLIP peptide in mice immunised with the group 1 allergen of house dust mite. Int Immunol 8: 1091–1098, 1996
Heldin CH: Dimerisation of cell surface receptors in signal transduction. Cell 80: 203–223, 1995
Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212, 1990
Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 76: 263–274, 1994
Germain RN, Hendrix LR: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353: 134–139, 1991
Goodman S, Sawada T, Barbosa JA, Cole B, Pergolizzi R, Silver J, Mellines E, Chang MY: Mutational analysisof two DRα residues involved in dimers of HLA-DR molecules. J Immunol 155: 1210–1217, 1995
Sadegh-Nasseri S, Stern LJ, Wiley DC, Germain RN: MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370: 647–650, 1994
Ramachandra L, Kovats S, Eastman S, Rudensky AY: Variation in HLA-DM expression influences conversion of MHC class II αβ:class II-associated invariant chain peptide complexes to mature peptide-bound class II αβ dimers in a normal B cell line. J Immunol 156: 2196–1204, 1996
Dianzani U, Shaw A, al Ramadi B, Kubo RT, Janeway CJ: Physical association of CD4 with the T cell receptor. J Immunol 148: 678–688, 1992
Kupfer A, Singer SJ, Janeway CJ, Swain SL: Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of the helper T cells and antigen presenting cells. Proc Natl Acad Sci 84: 5888–5892, 1987
Veillette A, Bookman MA, Horak EM, Bolen JB: The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine kinase p56lck. Cell 55: 301–308, 1988
Cammarota G, Scheirle A, Takacs B, Doran DM, Knorr R, Bannwarth W, Guardiola J, Sinigaglia F: Identification of a CD4 binding site on the b2 domain of HLA-DR molecules. Nature 356: 799–801, 1992
Konig R, Huang LY, Germain RN: MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356: 796–798, 1992
Konig R, Shen X, Germain RN: Involvement of both major histocompatibility complex class II a and b chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J Exp Med 182: 779–787, 1995
Hampl J, Chien YH, Davis MM: CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7: 379–385, 1997
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayball, J.D., Lake, R.A. The immune function of MHC class II molecules mutated in the putative superdimer interface. Mol Cell Biochem 273, 1–9 (2005). https://doi.org/10.1007/s11010-005-5281-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-5281-4